Microsoft (MSFT): How Recent AI Advances Shape the Stock’s Valuation Outlook

If you’re weighing your next move with Microsoft (MSFT), you’re not alone. Recent headlines about the company’s in-house AI launches, like MAI-Voice-1 and MAI-1 Preview, have caught the eye of investors and tech enthusiasts alike. Microsoft’s push into its own AI models, breaking out from its long-standing reliance on OpenAI, signals that the company is doubling down on building its own AI ecosystem at a time when the market is buzzing about the power and promise of enterprise AI.

All this excitement hasn’t guaranteed a straight path upward for the stock, though. Over the past month, Microsoft shares have slid by about 5%, despite posting a 5% bounce across the past three months and advancing 23% in the last year. That’s a decent stretch of growth, but it comes as Microsoft continues to expand Copilot across new industries, settles legal disputes, and weathers occasional pullbacks tied to broader tech sector swings and competitive headlines from peers like OpenAI.

So, after a year with both surges and setbacks, is Microsoft stock trading at a discount that’s too good to pass up, or has the market already factored in its AI ambitions and future growth potential?

Advertisement

Most Popular Narrative: 17% Overvalued

According to the narrative by Unike, Microsoft is currently viewed as trading above its fair value, with projections that anticipate major growth drivers in the years ahead.

AI and Cloud Dominance: Increased enterprise AI adoption will drive higher Azure demand and enhance productivity tools (Copilot, Dynamics AI).

Cybersecurity Expansion: Microsoft is growing its security software business, competing with CrowdStrike, Palo Alto, and Zscaler.

Curious how one growth thesis sees Microsoft becoming even more dominant? The narrative hinges on ambitious revenue expectations and higher future profitability margins, all built into its fair value calculation. What unique assumptions turn these projections into a towering price estimate? See which bold forecasts fuel this attention-grabbing valuation.

Result: Fair Value of $423.14 (OVERVALUEED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, if Copilot adoption slows or regulatory scrutiny increases, Microsoft’s bullish AI story could be undermined and fresh questions could be raised about its valuation.

Find out about the key risks to this Microsoft narrative.

Another View: SWS DCF Model Suggests Value Is Closer Than It Appears

While the popular narrative calls Microsoft overvalued, our SWS DCF model tells a different story and indicates that the stock is trading slightly below its estimate of fair value. Could the real opportunity be hiding in plain sight?

Look into how the SWS DCF model arrives at its fair value.
MSFT Discounted Cash Flow as at Sep 2025
MSFT Discounted Cash Flow as at Sep 2025
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Microsoft for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Microsoft Narrative

If you want to dig into the numbers or challenge these perspectives, you can craft your own viewpoint with just a few clicks: Do it your way.

A great starting point for your Microsoft research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.

Looking for More Smart Investment Opportunities?

Why limit your portfolio to one tech giant when there is a whole world of untapped stock prospects? Open doors to new possibilities with some of the market’s most exciting themes today. Do not let these powerful opportunities pass you by.

  • Grow your wealth with companies offering sustainable cash flows and attractive prices by targeting undervalued stocks based on cash flows in the market right now.
  • Boost your passive income with consistent earners who pay robust yields. Start your search with dividend stocks with yields > 3% to spot dependable income opportunities.
  • Ride the AI innovation wave by seeking out the most promising AI penny stocks transforming industries with advanced technology and machine learning breakthroughs.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Kshitija Bhandaru

Kshitija Bhandaru

Kshitija (or Keisha) Bhandaru is an Equity Analyst at Simply Wall St and has over 6 years of experience in the finance industry and describes herself as a lifelong learner driven by her intellectual curiosity. She previously worked with Market Realist for 5 years as an Equity Analyst.

About NasdaqGS:MSFT

Microsoft

Develops and supports software, services, devices, and solutions worldwide.

Very undervalued with outstanding track record and pays a dividend.

Advertisement

Weekly Picks

LO
Lou_Basenese
OPTH logo
Lou_Basenese on Optimi Health ·

The Only Psychedelic Company Already Selling MDMA and Psilocybin to Real Patients, Yet Priced Like It Doesn’t Exist

Fair Value:US$1155.3% undervalued
51 users have followed this narrative
2 users have commented on this narrative
9 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4849.2% undervalued
205 users have followed this narrative
6 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43038.1% undervalued
9 users have followed this narrative
1 users have commented on this narrative
3 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9956.4% undervalued
13 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative

Updated Narratives

ON
LOT logo
Ontological on Lotus Technology ·

Lotus Tech, Finloop and FOMO Pay Collaborate to Explore Vehicle Tokenization

Fair Value:US$2.463.9% undervalued
1 users have followed this narrative
1 users have commented on this narrative
0 users have liked this narrative
NE
AIIO logo
newsfinder11221 on Robo.ai ·

Robo.ai (NASDAQ: AIIO): Building the Infrastructure Behind the AI Revolution

Fair Value:US$540.4% undervalued
1 users have followed this narrative
3 users have commented on this narrative
0 users have liked this narrative
EU
European_Hidden_Gem_Stocks
ALMIN logo
European_Hidden_Gem_Stocks on MINT Société anonyme ·

Mint SA: A French Micro-Cap Energy Retailer Worth Watching

Fair Value:€1153.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.917.3% undervalued
88 users have followed this narrative
0 users have commented on this narrative
6 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.8% undervalued
199 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6513.7% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0